GTCR Co-CEO and Managing Director Collin Roche reflects on the private equity landscape, emphasizing the importance of value creation over merely capitalizing on rising prices.…
When Roche Holding acquired full ownership of Genentech last year, the $46.8 billion deal was the culmination of a more than 20-year relationship between the Swiss pharmaceutical giant and the Silicon Valley biotechnology company.…
